Xinguo Jiang

Title: The Innovations of Xinguo Jiang

Introduction

Xinguo Jiang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing topical preparations that address skin toxicity caused by anti-tumor drugs. His innovative approach combines scientific research with practical applications to improve patient care.

Latest Patents

Xinguo Jiang holds a patent for a topical preparation containing vitamin K1 and a preparation method thereof. This preparation includes 0.01-5% of vitamin K1, 0.1-25% of a transdermal enhancer, and 70-99% of a matrix for the topical preparation. The transdermal enhancer is composed of urea, menthol, and oil in a specific mass ratio. This formulation is designed to treat moderate and severe skin toxicity related to epidermal growth factor receptor (EGFR) anti-tumor drugs. It effectively addresses conditions such as acne-like rash, pruritus, red swelling, dry skin, and mucositis, ensuring that patients can continue their treatment with anti-EGFR targeting drugs.

Career Highlights

Xinguo Jiang is associated with Yangzijiang Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd. His work focuses on developing innovative solutions that enhance the efficacy of treatments for patients undergoing cancer therapy. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Xinguo Jiang has collaborated with notable colleagues, including Haihua Ni and Feng Jiang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Xinguo Jiang's contributions to the field of pharmaceuticals, particularly through his patent for a topical preparation containing vitamin K1, demonstrate his commitment to improving patient outcomes. His work continues to influence the development of effective treatments for skin toxicity associated with cancer therapies.